Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs1823685 | chr2:61435085 | G/A | 6.7E-5 | 177 | 23.77 | 31.48 | 10.3 | KM Plot |
PCPG | rs182657812 | chr2:118540747 | A/G | 1.67E-5 | 177 | 24.85 | 30.33 | 11.65 | KM Plot |
PCPG | rs182963805 | chr12:56671147 | G/A | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs183041801 | chr16:90022269 | A/G | 1.45E-8 | 171 | 25.67 | 20.17 | 6.62 | KM Plot |
PCPG | rs1830844 | chr10:26931449 | C/T | 0.000146 | 177 | 26.95 | 21.55 | 24.53 | KM Plot |
PCPG | rs183417401 | chr5:171530761 | T/A | 0.000107 | 176 | 25.87 | 20.37 | 17.12 | KM Plot |
PCPG | rs183670 | chr5:33992261 | G/A | 1.0E-5 | 172 | 24.62 | 30.93 | 25.17 | KM Plot |
PCPG | rs183689857 | chr2:118563281 | A/C | 1.77E-5 | 177 | 25.28 | 25.97 | 11.65 | KM Plot |
PCPG | rs183931511 | chr5:175564977 | G/C | 2.8E-6 | 174 | 25.87 | 21.77 | 22.37 | KM Plot |
PCPG | rs184104056 | chr12:56688237 | G/A | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs185011215 | chr7:1110322 | A/G | 0.000259 | 174 | 25.7 | 24.95 | 49.58 | KM Plot |
PCPG | rs1853659 | chr6:150396303 | A/G | 3.95E-5 | 171 | 3.17 | 24.62 | 25.92 | KM Plot |
PCPG | rs1861617 | chr2:230492411 | A/G | 1.23E-8 | 172 | 5.18 | 22.35 | 25.87 | KM Plot |
PCPG | rs1865037 | chr19:19709129 | G/A | 0.000453 | 175 | 25.42 | 26.57 | 20.25 | KM Plot |
PCPG | rs187477195 | chr12:31791509 | A/G | 0.000374 | 174 | 24.5 | 28.3 | 16.83 | KM Plot |